Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea

Por Renso, Rossella, Aroldi, Andrea, Pioltelli, Pietro, Gambacorti-Passerini, Carlo, Elli, Elena Maria
Publicado no Blood Cancer J (2018)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis

Por Elli, Elena Maria, Belotti, Angelo, Aroldi, Andrea, Parma, Matteo, Pioltelli, Pietro, Pogliani, Enrico Maria
Publicado em 2014